Clinical Trial Update: Observational Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in Patients With Systemic Anthrax

View source ↗

Summary

Observational study evaluating the clinical benefit and safety of AIGIV (ANTHRASIL) in patients with systemic anthrax; sponsor Emergent BioSolutions, status NOT…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anthrax

Drugs mentioned

• AIGIV (ANTHRASIL) (Anthrax immune globulin intravenous)

Snippet

Sponsor: Emergent BioSolutions | Conditions: Anthrax | Status: NOT_YET_RECRUITING